AbbVie (NYSE:ABBV) PT Raised to $212.00 at Barclays
AbbVie (NYSE:ABBV – Get Free Report) had its price objective boosted by equities researchers at Barclays from $200.00 to $212.00 in a research report issued on Monday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s target price suggests a potential upside of 9.85% from the stock’s current price. Several other […]
9 Oct 08:24 · The Markets Daily